| 1 | 7491961 | Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression. | Am J Physiol | 1995 Nov |
1 |
| 2 | 7932178 | YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats. | J Pharmacol Exp Ther | 1994 Sep |
2 |
| 3 | 8698625 | Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022. | Jpn J Cancer Res | 1996 Jul |
2 |
| 4 | 8886928 | Antagonistic effect of YM022, an antiulcer agent in rats, on human cholecystokinin (CCK)B/gastrin receptor. | Jpn J Pharmacol | 1996 Aug |
1 |
| 5 | 9125636 | YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs. | Dig Dis Sci | 1997 Apr |
1 |
| 6 | 9331153 | Role of gastrin/CCK-B receptor in the regulation of gastric acid secretion in rat. | Dig Dis Sci | 1997 Sep |
2 |
| 7 | 9584331 | Sustained cholecystokinin-B/gastrin receptor blockade does not impair basal or histamine-stimulated acid secretion in chronic gastric fistula rats. | Pharmacol Toxicol | 1998 Apr |
1 |
| 8 | 9646057 | YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands. | Fundam Clin Pharmacol | 1998 |
1 |
| 9 | 10821801 | Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022. | Br J Pharmacol | 2000 Jun |
2 |
| 10 | 10961714 | Acid secretory changes in streptozotocin-diabetic rats: different responses to various secretagogues. | Dig Dis Sci | 2000 Jul |
1 |
| 11 | 12388195 | Gastrin enhances gastric mucosal integrity through cyclooxygenase-2 upregulation in rats. | Am J Physiol Gastrointest Liver Physiol | 2002 Dec |
1 |
| 12 | 12921485 | New molecular targets for treatment of peptic ulcer disease. | Drugs | 2003 |
1 |
| 13 | 21334366 | Formalin-induced long-term secondary allodynia and hyperalgesia are maintained by descending facilitation. | Pharmacol Biochem Behav | 2011 May |
1 |
| 14 | 21354865 | Descending facilitatory pathways from the rostroventromedial medulla mediate naloxone-precipitated withdrawal in morphine-dependent rats. | J Pain | 2011 Jun |
1 |
| 15 | 24101389 | Gastrin promotes intestinal polyposis through cholecystokinin-B receptor-mediated proliferative signaling and fostering tumor microenvironment. | J Physiol Pharmacol | 2013 Aug |
2 |
| 16 | 25707915 | The Pronociceptive Effect of Paradoxical Sleep Deprivation in Rats: Evidence for a Role of Descending Pain Modulation Mechanisms. | Mol Neurobiol | 2016 Apr |
1 |
| 17 | 29717112 | Gastrin stimulates pancreatic cancer cell directional migration by activating the Gα12/13-RhoA-ROCK signaling pathway. | Exp Mol Med | 2018 May 1 |
1 |
| 18 | 31430329 | Islets from human donors with higher but not lower hemoglobin A1c levels respond to gastrin treatment in vitro. | PLoS One | 2019 |
6 |
| 19 | 33952826 | Rapid Increase of Gastrointestinal P-Glycoprotein Functional Activity in Response to Etoposide Stimulation. | Biol Pharm Bull | 2021 |
1 |
| 20 | 34748768 | Spinal CCK contributes to somatic hyperalgesia induced by orofacial inflammation combined with stress in adult female rats. | Eur J Pharmacol | 2021 Dec 15 |
2 |
| 21 | 34779255 | The hyperthermic effect of central cholecystokinin is mediated by the cyclooxygenase-2 pathway. | Am J Physiol Endocrinol Metab | 2022 Jan 1 |
1 |